This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Congenital malformations of aortic and mitral valves
Q17_CONGEN_MALFO_AORTIC_MITRAL_VALVES
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1534 |
4. Check minimum number of eventsNone |
1534 |
5. Include endpointsNone |
1534 |
6. Filter based on genotype QC (FinnGen only) |
1534 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- Q2
Similar endpoints
↥List of similar endpoints to
Congenital malformations of aortic and mitral valves
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1534 | 526 | 1008 |
| Unadjusted period prevalence (%) | 0.35 | 0.18 | 0.44 |
| Median age at first event (years) | 51.04 | 46.82 | 53.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1355
- Matched controls
- 13548
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
46.3
323.0
583
217
I35.0
ICD-10 Finland
Aortic (valve) stenosis
42.0
323.0
525
201
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
12.9
323.0
828
1466
Q23.11
ICD-10 Finland
Bicuspid aortic valve
4503599627370496.0
323.0
1161
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
23.2
323.0
509
342
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
47.6
323.0
419
126
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
35.2
323.0
468
200
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
57.5
299.0
352
82
B01AA03
ATC
warfarin; systemic
11.3
297.5
666
1069
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
60.2
292.1
341
75
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
10.1
275.0
656
1147
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
125.9
225.7
239
23
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
6.4
175.8
566
1356
WX872
NOMESCO Finland
Intensive care
13.5
165.9
306
287
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.2
150.5
481
1101
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
149.8
141
*
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
+∞
129.3
122
*
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
44.8
128.6
159
40
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
124.1
800
3598
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
7.7
122.8
314
511
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
121.7
115
*
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
36.3
119.7
155
48
C07AB07
ATC
bisoprolol; oral
3.9
117.8
763
3386
K83
ICPC
Heart valve disease NOS
57.2
117.7
139
27
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.8
110.9
279
438
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
122.4
95.4
102
9
PD5BD
NOMESCO Finland
Extensive CT of aorta
22.8
94.0
138
67
FCA50
NOMESCO Finland
Resection and reconstruction of ascending aorta using tube graft
86.1
86.3
96
12
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
79.7
337
955
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
17.9
79.2
126
77
XF404
NOMESCO Finland
Ambulatory ECG
5.6
77.9
250
526
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
8.0
72.6
174
245
201
Kela drug reimbursment
Chronic cardiac insufficiency
9.0
70.4
156
193
PC1BD
NOMESCO Finland
Extensive CT of thoracic aorta
63.5
67.3
78
13
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
122.9
65.5
70
6
XF402
NOMESCO Finland
ECG with work load test
4.5
63.3
252
659
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
15.7
63.0
105
72
TPH07
NOMESCO Finland
Cathetrisation of artery
4.5
62.2
244
628
B01AB05
ATC
enoxaparin; parenteral
3.0
61.9
474
2084
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
59.8
57
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
3.5
59.8
336
1181
C03CA01
ATC
furosemide; systemic
3.2
59.0
377
1456
XF400
NOMESCO Finland
ECG with 12 standard connections
3.4
58.8
334
1183
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
58.0
510
2426
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.6
54.0
167
329
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
53.5
51
*
FM2CE
NOMESCO Finland
NA
13.6
52.7
93
73
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
69.6
52.6
60
9
AB1
HP
AVR mechanical
57.9
52.0
61
11
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
+∞
50.3
48
*
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
49.3
47
*
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
+∞
49.3
47
*
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
48.2
46
*
TFP20
NOMESCO Finland
Cardiodefibrillation
4.9
47.8
166
372
31
HP
Congenital heart failure surgery
+∞
45.0
43
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
82.9
43.1
48
6
XF640
NOMESCO Finland
NA
8.6
42.5
95
118
XF622
NOMESCO Finland
Measurement of minute volume of heart
69.4
41.3
47
7
K84
ICPC
Heart disease other
9.2
40.7
87
100
XFE00
NOMESCO Finland
Epicardial ultrasonography
8.9
40.3
88
105
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
19.6
39.5
60
32
AN1
HP
Coronary angiography
3.6
38.8
195
611
R4110
NOMESCO Finland
Physiotherapy
2.4
38.7
436
2265
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
37.7
36
*
C03DA01
ATC
spironolactone; oral
3.7
37.6
181
547
WX402
NOMESCO Finland
General anaesthesia
2.6
37.5
314
1388
XF600
NOMESCO Finland
Bloodpressure measurement
4.0
37.3
160
438
61
HP
Catheterization and pressure measurement of the left side of the heart
13.6
36.7
64
49
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
100.3
35.9
39
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
35.0
562
3401
PD5BG
NOMESCO Finland
MRI examination of thoracal and abdominal aortta with high intensity magnet
80.3
35.0
39
5
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
7.0
34.9
89
135
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
12.7
34.4
62
51
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
23.1
34.1
49
22
WZC30
NOMESCO Finland
Teaching
2.9
34.0
232
898
FCA70
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft
95.0
33.9
37
*
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
34.1
33.3
43
13
Z2221
NOMESCO Finland
Medical doctor
2.2
32.7
423
2310
7471A
ICD-9 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]
+∞
32.4
31
*
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
+∞
32.4
31
*
74719
ICD-8 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta
324.3
32.0
32
*
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
116.1
31.8
34
*
PD5DG
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
319.9
30.9
31
*
I44.2
ICD-10 Finland
Atrioventricular block, complete
9.2
30.6
65
74
K78
ICPC
Atrial fibrillation/flutter
4.2
30.4
120
303
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
30.3
29
*
WX892
NOMESCO Finland
Monitored bed care
3.4
30.0
153
482
J01CA04
ATC
amoxicillin; systemic
2.3
30.0
1136
9436
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.4
29.8
114
279
62
HP
Catheterization and pressure measurement of the right side of the heart
58.0
29.2
34
6
I97.0
ICD-10 Finland
Postcardiotomy syndrome
28.6
29.0
39
14
C01AA05
ATC
digoxin; systemic
4.6
28.9
105
244
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
28.3
145
457
PD5AD
NOMESCO Finland
CT of aorta
12.3
28.1
51
43
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
27.8
613
4084
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
148.0
27.7
29
*
ZXD05
NOMESCO Finland
Urgent procedure
2.0
27.0
423
2466
C01BD01
ATC
amiodarone; systemic
6.3
26.8
73
122
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.4
26.5
71
116
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
16.6
26.4
42
26
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
26.1
25
*
AB2
HP
AVR bio, stent
24.6
25.8
36
15
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
25.6
25.3
35
14
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
+∞
25.1
24
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.8
25.0
72
129
WW502
NOMESCO Finland
Autotransfusion
14.4
24.9
42
30
I35.8
ICD-10 Finland
Other aortic valve disorders
39.6
24.9
31
8
I50.9
ICD-10 Finland
Heart failure, unspecified
3.1
24.7
149
527
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
4.6
24.6
89
206
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.5
24.6
90
211
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
28.1
24.5
33
12
C09AA05
ATC
ramipril; oral
2.2
24.5
302
1582
AJ2
HP
Reconstruction of the ascending aorta
49.3
24.3
29
6
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
+∞
24.0
23
*
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
14.7
24.0
40
28
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
19.4
24.0
36
19
PD5CD
NOMESCO Finland
Very extensive CT angiography of aorta
23.4
22.6
32
14
FMD40
NOMESCO Finland
Replacement of aortic root using pulmonary autograft and reimplantation of coronary arteries (Ross)
+∞
21.9
21
*
Q23.8
ICD-10 Finland
Other congenital malformations of aortic and mitral valves
+∞
21.9
21
*
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
21.9
21
*
7463A
ICD-9 Finland
Other congenital anomalies of heart, Congenital stenosis of aortic valve[STENOSIS VALVULAE AORTAE CONGENITA]
+∞
21.9
21
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
25.5
21.8
30
12
ZXE00
NOMESCO Finland
One hour or less
1.8
21.8
539
3641
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
14.8
21.7
36
25
21
HP
Aortic Valve Replacement (AVR)
223.4
21.7
22
*
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
+∞
20.9
20
*
Q25.3
ICD-10 Finland
Stenosis of aorta
+∞
20.9
20
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
20.5
396
2449
K99
ICPC
Cardiovascular disease other
5.8
20.2
58
104
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
20.1
468
3080
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
5.0
19.6
64
134
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
25.0
19.6
27
11
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
19.5
323
1885
R01.1
ICD-10 Finland
Cardiac murmur, unspecified
5.6
19.2
56
103
FC1BC
NOMESCO Finland
Extensive angiography of thoracal aortta
26.5
19.2
26
10
WX704
NOMESCO Finland
Intubation
2.9
19.0
118
425
WX882
NOMESCO Finland
High dependency care
3.6
19.0
89
262
I35
ICD-10 Finland
Nonrheumatic aortic valve disorders
55.8
19.0
22
*
Q20.48
ICD-10 Finland
Single ventricle
+∞
18.8
18
*
Q23.9
ICD-10 Finland
Congenital malformation of aortic and mitral valves, unspecified
+∞
18.8
18
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
3.4
18.8
95
297
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
70.9
18.7
21
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
8.7
18.7
40
47
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
192.5
18.6
19
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
18.5
1038
8780
207
Kela drug reimbursment
Chronic arrhythmias
2.4
18.4
162
716
C07AB02
ATC
metoprolol; systemic
2.1
18.3
224
1155
Q23.1
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
17.7
17
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.1
17.7
233
1238
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
4.2
17.0
65
160
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
16.7
16
*
Q21.0
ICD-10 Finland
Ventricular septal defect
+∞
16.7
16
*
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
+∞
16.7
16
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
+∞
16.7
16
*
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
35.5
16.7
21
6
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
6.7
16.7
42
64
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
16.5
16.6
26
16
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
16.5
97
338
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
16.3
273
1586
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.0
16.3
98
345
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
16.1
285
1691
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.6
16.1
47
87
C09CA01
ATC
losartan; oral
1.9
16.0
274
1608
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
15.8
104
387
I34.1
ICD-10 Finland
Mitral (valve) prolapse
4.7
15.7
53
116
74673
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae aortae
+∞
15.6
15
*
I37.0
ICD-10 Finland
Pulmonary valve stenosis
161.7
15.5
16
*
FMC20
NOMESCO Finland
Suture of leaflet of aortic valve
161.7
15.5
16
*
K22
ICPC
Risk factor cardiovascular disease
3.6
15.4
71
207
R50.9
ICD-10 Finland
Fever, unspecified
2.0
15.3
218
1191
7AX01
NOMESCO Finland
NA
29.0
15.2
20
7
Q25.48
ICD-10 Finland
Other congenital malformations of the aorta
+∞
14.6
14
*
5513
FHL
Coarctation resection, plastic or bypass
+∞
14.6
14
*
RS224
NOMESCO Finland
NA
8.2
14.6
32
40
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.8
14.6
41
73
I38
ICD-10 Finland
Endocarditis, valve unspecified
36.4
14.5
18
5
5253
FHL
Cardiac lung machine
14.6
14.1
23
16
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
3.6
13.8
62
177
Z98.8
ICD-10 Finland
Other specified postsurgical states
5.6
13.6
39
71
FDJ00
NOMESCO Finland
End to end reconstruction of aorta for coarctation
+∞
13.6
13
*
Q23.20
ICD-10 Finland
Congenital mitral stenosis
+∞
13.6
13
*
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
13.6
13
*
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
+∞
13.6
13
*
FXA13
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion
+∞
13.6
13
*
FMC96
NOMESCO Finland
Other operation on aortic valve for insufficiency
+∞
13.6
13
*
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
5.7
13.2
37
66
R06.0
ICD-10 Finland
Dyspnoea
1.8
13.2
265
1628
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
13.2
103
427
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.7
13.1
92
356
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
13.0
376
2570
AA1AD
NOMESCO Finland
CT of head and brain
1.8
13.0
257
1573
PD5CM
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
70.5
12.6
14
*
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
11.1
12.5
23
21
FDJ42
NOMESCO Finland
Percutaneous transluminal angioplasty of thoracic aorta in coarctation
+∞
12.5
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
12.5
258
1598
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
12.5
212
1232
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
24.5
12.5
17
7
Z3231
NOMESCO Finland
Registered nurse
1.6
12.3
373
2578
C08CA01
ATC
amlodipine; oral
1.6
12.1
365
2513
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.6
11.9
85
334
G04BE03
ATC
sildenafil; oral
5.3
11.8
35
67
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
11.6
85
341
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
+∞
11.5
11
*
FMA20
NOMESCO Finland
Plastic repair of aortic valve for stenosis
+∞
11.5
11
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
11.5
11
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
11.5
11
*
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
+∞
11.5
11
*
I47.1
ICD-10 Finland
Supraventricular tachycardia
3.0
11.4
65
223
FFM10
NOMESCO Finland
Occlusion or excision of atrial appendage externally with a closing device
15.2
11.3
18
12
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
6.3
11.2
29
47
FM1CD
NOMESCO Finland
Very extensive CT of heart
17.2
11.2
17
10
FPD10
NOMESCO Finland
Surgical ablation of atrial fibrillation
25.2
11.1
15
6
WX870
NOMESCO Finland
Other postsurgical intensive care
11.3
11.1
20
18
211
HP
AVR mechanical
43.7
10.9
13
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
10.8
572
4470
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
5.4
10.8
31
58
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
3.0
10.7
61
208
I71.1
ICD-10 Finland
Thoracic aortic aneurysm, ruptured
28.3
10.7
14
5
ZXX09
NOMESCO Finland
Extent of procedure, more than 8 units
60.5
10.6
12
*
FCB40
NOMESCO Finland
Resection and reconstruction of aortic arch using tube graft
60.5
10.6
12
*
ZX199
NOMESCO Finland
Other rote
8.6
10.5
22
26
K29
ICPC
Cardiovascular sympt/complt other
3.2
10.5
53
168
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
10.4
10
*
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
+∞
10.4
10
*
Q21.30
ICD-10 Finland
Tetralogy of Fallot
+∞
10.4
10
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
10.4
10
*
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.4
216
1335
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
6.4
10.3
26
41
FM1AD
NOMESCO Finland
CT of heart
32.8
10.3
13
*
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
10.3
120
603
R55
ICD-10 Finland
Syncope and collapse
2.1
10.3
120
604
I50.0
ICD-10 Finland
Congestive heart failure
2.9
10.3
62
222
81
HP
Angiography of the heart and coronary arteries
2.8
10.3
64
233
Z94.1
ICD-10 Finland
Heart transplant status
9.6
10.3
20
21
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
23.5
10.2
14
6
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.9
10.2
61
217
I71.01
ICD-10 Finland
Aneurysm of the descending aorta
40.4
10.0
12
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.6
10.0
43
121
I50.1
ICD-10 Finland
Left ventricular failure
3.2
9.8
50
160
FM1DE
SPAT
NA
20.2
9.8
14
7
A02BC02
ATC
pantoprazole; systemic
1.4
9.8
683
5601
C09AA04
ATC
perindopril; oral
2.7
9.8
66
254
TFP34
NOMESCO Finland
Electrophysiological investigation
3.1
9.7
51
167
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
9.7
79
338
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
9.7
414
3072
XF620
NOMESCO Finland
Examination of circulation with color method
11.5
9.6
17
15
TFJ02
NOMESCO Finland
Muscle biopsy of heart
11.5
9.6
17
15
C09AA02
ATC
enalapril; systemic
1.7
9.4
197
1216
3A566
NOMESCO Finland
NA
100.7
9.4
10
*
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
100.7
9.4
10
*
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
30.2
9.4
12
*
C10AA05
ATC
atorvastatin; oral
1.5
9.4
395
2916
FMC10
NOMESCO Finland
Reduction of leaflet of aortic valve
+∞
9.4
9
*
1EA01
NOMESCO Finland
NA
+∞
9.4
9
*
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
9.4
9
*
GAB00
NOMESCO Finland
Emergency thoracotomy
+∞
9.4
9
*
FLE96
NOMESCO Finland
Other repair of outlet obstruction of left ventricle
+∞
9.4
9
*
7454B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]
+∞
9.4
9
*
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
21.8
9.4
13
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
9.3
116
599
FM1BD
NOMESCO Finland
Extensive CT of heart
13.8
9.2
15
11
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
9.1
95
455
UGC02
NOMESCO Finland
Rigid bronchoscopy
9.1
9.0
18
20
5273
FHL
Repair with flap prosthesis or graft
36.9
9.0
11
*
XQ903
NOMESCO Finland
Production of other scan or drawing
36.9
9.0
11
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.5
8.9
70
291
C07AA07
ATC
sotalol; systemic
3.3
8.9
43
133
R04.0
ICD-10 Finland
Epistaxis
2.2
8.8
84
387
FGD00
NOMESCO Finland
Repair of tricuspid valve using suture
50.3
8.7
10
*
324
NOMESCO Finland
NA
27.7
8.5
11
*
Z50.0
ICD-10 Finland
Cardiac rehabilitation
7.4
8.5
19
26
7463D
ICD-9 Finland
Other congenital anomalies of heart, Congenital stenosis of aortic valve[BIKUSPINEN AORTALÄPPÄ]
90.6
8.4
9
*
I33.9
ICD-10 Finland
Acute endocarditis, unspecified
12.8
8.4
14
11
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
8.3
8
*
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
+∞
8.3
8
*
FBA96
NOMESCO Finland
Other suture or repair of pulmonary artery
+∞
8.3
8
*
FJE42
NOMESCO Finland
Percutaneous transluminal expansion of pulmonary valve
+∞
8.3
8
*
Q32.11
ICD-10 Finland
Congenital tracheo-esophageal fissure
+∞
8.3
8
*
K73
ICPC
Congenital anomaly cardiovascular
+∞
8.3
8
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
8.3
8
*
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
+∞
8.3
8
*
FDA96
NOMESCO Finland
Other operation for HLHS
+∞
8.3
8
*
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
8.3
8
*
FAE96
NOMESCO Finland
Other connection to pulmonary artery from superior vena cava
+∞
8.3
8
*
R42
ICD-10 Finland
Dizziness and giddiness
1.7
8.3
196
1250
C09CA06
ATC
candesartan; oral
1.6
8.3
215
1411
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
8.2
57
224
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
14.6
8.2
13
9
602
Kela drug reimbursment
Children's severe malnutrition
4.1
8.2
30
74
J01DB01
ATC
cefalexin; oral
1.4
8.1
1009
9063
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
6.9
8.1
19
28
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
9.0
8.0
16
18
3A077
NOMESCO Finland
NA
22.2
8.0
11
5
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
5.9
8.0
21
36
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
5.6
8.0
22
40
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
7.9
52
199
RK260
NOMESCO Finland
NA
13.1
7.9
13
10
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
45.2
7.7
9
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
7.7
74
345
ZX120
NOMESCO Finland
Intravenous
1.9
7.6
114
633
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
25.1
7.6
10
*
I47.2
ICD-10 Finland
Ventricular tachycardia
3.8
7.6
30
80
AP1
HP
Catheterization of the left side of the heart
4.3
7.5
26
61
74699
ICD-8 Finland
Congenital anomalies of heart, Unspecified anomalies of heart
80.5
7.4
8
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.6
7.4
20
36
0034
NOMESCO Finland
NA
+∞
7.3
7
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
+∞
7.3
7
*
3AE00
NOMESCO Finland
NA
+∞
7.3
7
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
7.3
7
*
Q25.4
ICD-10 Finland
Other congenital malformations of aorta
+∞
7.3
7
*
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
7.3
7
*
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
+∞
7.3
7
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.8
7.2
46
170
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
6.3
7.2
18
29
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.4
7.1
32
95
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
20.1
7.1
10
5
1CX08
NOMESCO Finland
NA
8.0
7.1
15
19
3A064
NOMESCO Finland
NA
12.1
7.1
12
10
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.9
271
1955
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
13.8
6.9
11
8
3A019
NOMESCO Finland
NA
13.8
6.9
11
8
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
6.8
75
372
4241B
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[STENOSIS VALVULAE AORTAE (NON RHEUMATICA)]
40.2
6.8
8
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
6.7
199
1348
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
7.2
6.7
15
21
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.7
224
1559
GAB20
NOMESCO Finland
Median sternotomy
22.6
6.7
9
*
FN1BD
NOMESCO Finland
Extensive CT of coronary arteries
22.6
6.7
9
*
SPAT1097
SPAT
Recording of ECG
1.7
6.6
136
836
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.6
435
3456
G45.3
ICD-10 Finland
Amaurosis fugax
3.9
6.6
25
65
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
12.3
6.6
11
9
1AB02
NOMESCO Finland
NA
12.3
6.6
11
9
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.7
6.5
26
71
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
6.5
123
737
XF405
NOMESCO Finland
Symptom ECG
5.3
6.5
18
34
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.7
6.5
42
160
FXM00
NOMESCO Finland
Removal of extra-, para- or intracorporeal VAD
70.1
6.4
7
*
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
70.1
6.4
7
*
90492
NOMESCO Finland
NA
70.1
6.4
7
*
FCA96
NOMESCO Finland
Other repair of ascending aorta
70.1
6.4
7
*
I28.8
ICD-10 Finland
Other specified diseases of pulmonary vessels
70.1
6.4
7
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.0
6.4
78
401
3A422
NOMESCO Finland
NA
14.4
6.4
10
7
Z01.2
ICD-10 Finland
Dental examination
1.4
6.4
507
4149
K80
ICPC
Cardiac arrhythmia NOS
2.1
6.3
71
352
A41.8
ICD-10 Finland
Other specified sepsis
4.0
6.3
23
58
205
Kela drug reimbursment
Chronic hypertension
1.5
6.3
241
1729
I49.1
ICD-10 Finland
Atrial premature depolarization
2.8
6.3
38
140
FWW96
NOMESCO Finland
Other reoperation on heart or major thoracic vessels
18.1
6.3
9
5
AP3
HP
Catheterization of the right and left side of the heart
18.1
6.3
9
5
FMB10
NOMESCO Finland
Transannular expansion of aortic ostium
+∞
6.3
6
*
5207
FHL
VSD closure
+∞
6.3
6
*
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
+∞
6.3
6
*
74659
ICD-8 Finland
Congenital anomalies of heart, Maleformatio valvulae mitralis
+∞
6.3
6
*
Q25.21
ICD-10 Finland
Interrupted aortic arch
+∞
6.3
6
*
FJD20
NOMESCO Finland
Bypass of pulmonary valve with ventriculopulmonary prosthesis or homograft
+∞
6.3
6
*
Q87.14
ICD-10 Finland
Noonan's syndrome
+∞
6.3
6
*
7464A
ICD-9 Finland
Other congenital anomalies of heart, Congenital insufficiency of aortic valve
+∞
6.3
6
*
0557
NOMESCO Finland
NA
+∞
6.3
6
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.8
6.1
16
28
Z3226
NOMESCO Finland
Physiotherapist
1.5
6.1
225
1602
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
6.0
119
721
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1029
2796
9.14
307.65
5.2
3.1
ng/l
795.7
1196.3
2.84
961
2352
(3018677) aPTT in Platelet poor plasma by Coagulation assay
668
1806
5.78
245.40
4.5
2.7
s
30.9
29.9
3.33
656
1761
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
455
944
6.43
221.01
2.4
2.3
ug/l
18.3
7.3
11.87
442
845
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
410
780
6.81
217.27
4.2
2.8
ng/l
157.2
173.2
0.35
384
696
(3032080) INR in Blood by Coagulation assay
1027
4438
4.98
201.08
28.2
8.2
inr
1.9
1.2
50.79
314
1310
(3022217) INR in Platelet poor plasma by Coagulation assay
499
1240
5.48
196.77
52.4
19.4
inr
2.2
1.3
8.12
35
196
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
545
2092
3.49
111.14
5.5
3.6
ng/l
1998.0
622.8
6.69
495
1542
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
372
1287
3.50
86.94
3.6
4.6
u/l
283.8
247.5
3.88
358
1229
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
176
357
5.44
83.55
12.2
3.5
u/ml
0.3
0.3
0.20
114
197
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
63
33
19.87
80.97
10.6
6.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1209
8211
3.23
79.67
6.0
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
594
2810
2.82
79.39
2.7
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
918
5408
2.74
79.28
4.6
4.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
58
28
21.49
77.17
9.4
6.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
342
1203
3.37
77.04
9.5
10.1
mmol/l
7.5
8.6
3.03
332
1154
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
655
3332
2.69
74.96
2.9
2.2
u/l
392.3
288.2
1.24
627
3152
(3012095) Magnesium [Moles/volume] in Serum or Plasma
441
1914
2.83
67.81
7.1
5.0
mmol/l
0.8
0.8
1.62
427
1816
(3044640) Blood type and Crossmatch panel - Blood
669
3607
2.52
65.76
2.9
2.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1053
7057
2.57
63.31
9.8
5.4
mmol/l
6.5
6.7
2.01
1020
6616
(3036489) Thrombin time
187
503
4.09
62.15
4.5
3.5
s
22.9
22.1
0.97
178
461
(3023368) Bacteria identified in Blood by Culture
586
3071
2.47
60.05
5.5
4.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
713
4123
2.36
58.01
4.1
3.4
ng/l
81.7
62.4
0.50
507
2732
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
42
22
19.60
53.76
8.1
7.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
911
5990
2.28
52.93
6.9
6.8
umol/l
15.3
12.6
5.48
872
5708
(3016502) Oxygen saturation in Arterial blood
297
1177
2.89
52.86
18.7
9.5
%
97.5
95.8
5.17
290
1138
(3006576) Bicarbonate [Moles/volume] in Blood
50
39
13.22
52.18
9.6
6.3
mmol/l
25.9
25.0
0.70
45
33
(3027801) Oxygen [Partial pressure] in Arterial blood
312
1288
2.79
51.30
18.2
9.1
kpa
14.2
12.6
4.07
303
1245
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
312
1288
2.79
51.30
18.2
9.1
kpa
5.2
5.1
1.29
304
1242
(3003396) Base excess in Arterial blood by calculation
311
1287
2.78
50.86
18.2
9.1
mmol/l
1.0
1.0
0.04
271
1028
(3033658) Prothrombin time (PT) actual/Normal
559
3066
2.30
49.67
6.4
4.6
%
73.4
89.8
28.87
552
3006
(3002173) Hemoglobin [Mass/volume] in Arterial blood
277
1092
2.88
49.56
18.3
10.0
g/l
113.3
124.6
15.97
272
1055
(3014576) Chloride [Moles/volume] in Serum or Plasma
341
1511
2.62
48.49
10.1
8.2
mmol/l
105.9
104.3
8.64
336
1478
(3014007) Fractional oxyhemoglobin in Arterial blood
208
759
3.01
42.46
18.8
11.2
%
95.4
94.3
1.98
208
753
(3019550) Sodium [Moles/volume] in Serum or Plasma
1474
12644
5.24
42.39
26.2
14.9
mmol/l
139.3
139.7
8.24
1459
12328
(3023103) Potassium [Moles/volume] in Serum or Plasma
1476
12693
5.31
41.87
25.9
14.9
mmol/l
4.0
4.0
4.79
1461
12353
(3022948) Iron [Moles/volume] in Serum or Plasma
369
1821
2.35
40.80
2.9
2.7
umol/l
13.3
14.0
0.87
354
1706
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
83
169
5.13
38.81
10.8
6.6
mg/l
10.4
10.8
0.41
75
155
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
225
907
2.74
38.00
3.4
2.6
ml/min/173m2
62.2
70.9
2.16
78
340
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
327
1578
2.36
37.76
2.9
2.7
%
22.9
24.1
0.53
291
1383
(3004789) Transferrin [Mass/volume] in Serum or Plasma
341
1692
2.31
36.82
2.8
2.6
g/l
2.4
2.4
1.09
329
1585
(3024928) Oxygen saturation in Venous blood
101
252
4.22
36.79
6.7
5.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
285
1321
2.42
35.89
3.6
3.9
%
1.6
1.7
0.35
270
1210
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
175
642
2.95
35.15
25.9
12.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
184
699
2.85
34.65
6.0
4.4
g/l
121.3
131.3
6.84
178
684
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
639
4126
1.94
33.58
4.1
3.6
u/l
35.0
38.1
0.33
619
3922
(3000991) Gas panel - Venous blood
266
1248
2.37
32.35
15.6
10.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
177
695
2.75
31.21
18.9
7.9
mmol/l
25.0
24.5
1.25
169
650
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
804
5688
1.87
31.10
12.6
8.0
mmol/l
1.2
1.2
20.13
716
4907
(3019060) Gas panel - Arterial blood
180
716
2.72
30.94
13.5
5.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
752
5228
1.86
30.57
13.9
7.4
mmol/l
1.2
1.2
22.42
715
4802
(3014111) Lactate [Moles/volume] in Serum or Plasma
240
1103
2.39
30.47
15.2
9.1
mmol/l
1.2
1.4
1.47
233
1054
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1133
9096
1.94
27.92
7.8
7.5
u/l
80.9
83.1
0.73
1093
8617
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1428
12590
2.94
27.11
20.2
13.0
mg/l
34.2
24.0
20.40
1244
9661
(40761511) CBC panel - Blood by Automated count
1468
13168
3.67
26.52
19.7
11.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
325
1779
2.05
26.46
1.9
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
550
3589
1.83
26.37
1.4
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
309
1691
2.04
25.04
2.5
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
246
1247
2.16
24.38
1.9
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1474
13362
3.64
23.94
23.4
14.7
umol/l
79.0
77.4
1.14
1474
13357
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
452
2854
1.83
23.63
2.5
2.4
mg/l
3.2
2.9
1.91
416
2454
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1307
11254
2.09
23.28
16.9
11.7
ml/min/173m2
86.2
86.6
0.25
1145
9141
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
414
2558
1.85
23.15
3.4
2.1
mg/l
1.3
1.2
0.22
292
1906
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
243
1263
2.10
22.46
2.0
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
675
4845
1.70
22.19
6.7
5.7
g/l
36.0
36.2
0.43
638
4543
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
101
355
2.98
21.74
1.5
1.7
—
—
—
0
0
(3020891) Body temperature
120
463
2.73
21.74
8.8
5.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
122
476
2.70
21.62
2.0
2.0
g/l
1.2
1.5
1.70
81
415
(3002032) Base excess in Venous blood by calculation
252
1348
2.04
21.49
6.4
6.1
mmol/l
1.9
1.8
0.20
212
1071
(3021447) Carbon dioxide [Partial pressure] in Venous blood
250
1357
2.01
20.40
6.1
6.1
kpa
5.9
5.9
0.06
245
1322
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
209
1079
2.08
19.52
18.9
10.8
mmol/l
24.9
24.8
0.20
209
1073
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
75
243
3.19
18.56
1.4
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
189
973
2.07
17.72
3.8
3.4
e9/l
73.7
70.9
0.42
140
731
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
112
467
2.51
17.32
3.3
2.0
ug/l
2.6
2.2
0.12
102
420
(3001122) Ferritin [Mass/volume] in Serum or Plasma
684
5154
1.59
17.10
3.2
2.9
ug/l
199.5
135.3
0.41
649
4814
(44790047)
59
178
3.41
16.38
1.7
1.9
—
—
—
0
0
(44806118)
59
178
3.41
16.38
1.7
1.9
—
—
—
0
0
(44790048)
59
178
3.41
16.38
1.7
1.9
—
—
—
0
0
(44790049)
59
178
3.41
16.38
1.7
1.9
—
—
—
0
0
(3013512) EKG study
449
3088
1.64
16.17
5.7
3.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
84
319
2.73
15.69
1.7
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
742
5787
1.55
15.38
11.4
10.0
e9/l
0.0
0.0
0.29
644
4711
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
82
314
2.70
15.08
1.7
2.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
117
530
2.31
15.06
4.1
4.3
%
0.7
0.7
0.63
117
516
(3002385) Erythrocyte distribution width [Ratio]
1241
10927
1.71
14.98
25.8
15.9
%
13.6
13.5
0.89
1226
10713
(3002256) Pathology report gross observation
228
1377
1.77
13.02
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
224
1346
1.78
13.02
9.3
6.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
455
3280
1.55
12.91
7.8
7.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1437
13365
2.19
12.91
12.1
10.0
u/l
28.7
29.3
0.58
1400
12966
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
16
5
32.31
12.58
12.9
4.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
160
875
1.93
12.54
8.1
7.0
mmol/l
24.1
24.0
0.41
152
824
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
97
443
2.27
12.26
16.9
6.2
%
1.7
1.6
0.20
92
415
(3013707) Erythrocyte sedimentation rate by Westergren method
1035
8891
1.50
12.19
4.3
4.0
mm/h
10.3
10.3
0.00
983
8272
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1232
11006
1.61
12.02
4.5
4.2
mu/l
1.9
2.1
0.58
1148
10144
(3018738) Hemoglobin F/Hemoglobin.total in Blood
16
20
8.07
11.89
6.0
5.4
%
1.1
3.0
—
7
8
(3007461) Platelets [#/volume] in Blood
1504
14341
3.49
11.76
30.7
18.9
e9/l
234.2
249.2
17.34
1481
13954
(3024731) MCV [Entitic volume]
1504
14349
3.46
11.59
30.5
18.8
fl
90.1
90.1
0.08
1491
14175
(3035941) MCH [Entitic mass]
1504
14350
3.46
11.57
30.5
18.8
pg
30.1
30.2
1.27
1491
14175
(3026361) Erythrocytes [#/volume] in Blood
1504
14352
3.45
11.52
30.6
18.8
e12/l
4.5
4.6
25.55
1478
13933
(3010813) Leukocytes [#/volume] in Blood
1504
14354
3.44
11.48
30.7
18.9
e9/l
6.8
6.7
1.44
1479
13932
(3000963) Hemoglobin [Mass/volume] in Blood
1504
14357
3.43
11.42
31.2
18.9
g/l
132.7
138.9
38.10
1491
14176
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
126
657
2.00
11.33
1.7
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
234
1481
1.68
11.21
2.0
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
433
3176
1.51
11.04
4.3
4.1
ph
7.4
7.4
0.53
88
605
(3051651) Icteric interference index of Serum or Plasma
34
93
3.72
10.99
6.3
4.4
—
—
—
0
0
(3039000) Anion gap in Blood
63
250
2.59
10.85
23.2
8.7
mmol/l
10.4
11.3
1.90
58
224
(3047181) Lactate [Moles/volume] in Blood
79
349
2.33
10.81
20.2
7.4
mmol/l
1.3
1.3
0.17
72
303
(3018572) Chloride [Moles/volume] in Blood
63
251
2.57
10.77
23.2
8.7
mmol/l
107.0
105.8
1.67
58
225
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1277
11591
1.61
10.72
4.4
3.8
mmol/l
1.3
1.3
0.54
1215
10778
(3051611) Lipemic interference index of Serum or Plasma
39
119
3.34
10.71
6.2
4.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
53
196
2.77
10.48
1.5
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
781
6466
1.42
10.34
7.4
6.8
e9/l
0.0
0.0
0.19
699
5589
(3001604) Monocytes [#/volume] in Blood
779
6449
1.42
10.30
7.4
6.8
e9/l
0.6
0.6
0.86
698
5573
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
54
204
2.71
10.26
1.3
1.2
u/ml
5.2
3.4
0.24
25
76
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
41
133
3.14
10.22
3.1
2.4
pg
32.5
33.1
0.34
41
133
(3013650) Neutrophils [#/volume] in Blood by Automated count
867
7325
1.42
10.17
10.2
9.9
e9/l
4.1
4.0
0.34
778
6371
(3013115) Eosinophils [#/volume] in Blood
801
6676
1.42
10.13
7.9
7.2
e9/l
0.2
0.2
0.05
722
5877
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
223
2.62
10.12
1.5
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
346
2470
1.52
9.89
2.8
2.7
e6/l
4.0
4.8
0.57
299
2179
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
550
4302
1.43
9.85
3.6
3.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
90
437
2.13
9.82
18.1
6.3
%
1.0
0.9
1.35
85
410
(3003338) MCHC [Mass/volume]
1247
11320
1.54
9.78
28.0
16.2
g/l
333.5
334.4
2.98
1242
11240
(3002582) Erythrocytes [#/volume] in Urine
478
3649
1.45
9.74
3.6
3.4
e6/l
327.0
71.3
0.49
380
2809
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
52
201
2.64
9.47
1.3
1.2
u/ml
7.3
5.6
0.24
31
93
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
49
184
2.72
9.44
1.4
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
792
6639
1.40
9.40
7.5
6.8
e9/l
1.7
2.0
8.13
718
5858
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
56
226
2.53
9.35
1.5
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
440
3330
1.45
9.31
3.6
3.3
e6/l
0.4
0.4
0.08
348
2497
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1028
9021
1.42
9.30
3.8
3.5
pmol/l
14.9
14.7
1.92
948
8244
(3022096) Basophils/100 leukocytes in Blood
716
5909
1.40
9.27
7.7
7.1
%
0.7
0.7
0.30
684
5589
(3006504) Eosinophils/100 leukocytes in Blood
733
6077
1.39
9.22
7.6
7.0
%
3.1
3.0
0.59
697
5732
(3019069) Monocytes/100 leukocytes in Blood
736
6111
1.39
9.15
8.0
7.3
%
9.1
8.7
3.78
702
5784
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
44
160
2.80
9.01
1.5
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1311
12092
1.58
8.97
4.8
4.2
mmol/l
4.5
4.6
8.05
1258
11348
(42870588) Differential panel, method unspecified - Blood
557
4427
1.41
8.89
7.3
7.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
43
159
2.75
8.55
1.5
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
741
6206
1.38
8.51
7.6
6.8
%
58.1
55.5
7.31
707
5878
(3009542) Hematocrit [Volume Fraction] of Blood
1309
12104
1.56
8.47
24.7
13.9
%
39.7
40.9
7.55
1035
9421
(36304419) Bacteria [Presence] in Urine
429
3289
1.42
8.30
3.5
3.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
749
6300
1.37
8.30
7.7
7.0
%
26.3
29.5
13.36
713
5948
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1315
12219
1.53
7.81
5.3
4.5
mmol/l
2.7
2.8
5.77
1263
11382
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
184
1200
1.61
7.74
3.0
3.0
g/l
0.2
0.2
2.55
175
1129
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1296
12026
1.50
7.53
4.8
4.1
mmol/l
1.4
1.4
0.76
1242
11216
(3023199) Leukocytes [#/volume] in Pleural fluid
32
108
3.00
7.52
1.5
1.5
e6/l
2209.0
1804.7
0.23
26
71
(3018095) Leukocytes [#/volume] in Urine
525
4223
1.37
7.49
4.1
3.9
e6/l
129.1
73.5
0.41
399
2999
(3034426) Prothrombin time (PT)
18
43
4.22
7.02
1.2
1.3
—
—
—
0
0
(4268621)
37
141
2.66
7.00
2.6
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
137
853
1.67
6.93
11.4
6.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
209
1439
1.52
6.92
3.8
3.6
umol/l
9.4
8.2
0.38
194
1266
(3031040) Bacteria [#/volume] in Urine by Automated count
845
7374
1.32
6.73
4.3
3.9
e6/l
29.8
1324.5
1.09
13
106
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
160
1047
1.59
6.63
11.2
5.6
mmol/l
2.3
1.3
3.47
123
759
(3045788) Cell count panel - Pleural fluid
26
84
3.13
6.60
1.4
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
530
4335
1.34
6.60
1.8
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
24
74
3.28
6.57
3.6
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
207
1439
1.51
6.54
1.7
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
164
1085
1.57
6.49
11.1
5.6
kpa
5.1
5.1
0.23
159
1020
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1245
11552
1.41
6.41
4.2
4.1
mmol/l
5.9
5.9
0.84
1159
10640
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
110
660
1.72
6.40
1.6
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
162
1076
1.57
6.30
11.1
5.6
ph
7.4
7.4
0.26
13
102
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
34
132
2.61
6.23
1.9
3.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
28
98
2.89
6.22
1.5
1.4
e6/l
75115.0
21830.4
0.76
18
55
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
452
3640
1.34
6.17
3.0
2.7
u/l
60.8
57.5
0.47
419
3410
(3026782) Osmolality of Urine
306
2317
1.40
6.14
2.9
2.8
mosm/kgh2o
570.2
575.7
0.14
252
1987
(3012441) Differential panel - Pleural fluid
27
94
2.91
6.06
1.6
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
27
94
2.91
6.06
25.3
33.0
ug/l
160.5
133.5
0.86
20
83
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1186
10949
1.37
6.03
5.1
5.3
mmol/mol
38.1
39.5
6.44
1123
10276
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
44
3.90
5.99
1.2
1.1
%
69.8
94.0
2.04
12
24
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
63
327
1.97
5.84
9.9
7.8
iu/ml
909.4
403.3
—
10
52
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
69
370
1.91
5.82
2.2
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
14
32
4.41
5.77
15.5
16.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
53
262
2.06
5.63
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
53
262
2.06
5.63
1.5
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
66
353
1.91
5.62
2.2
1.7
u/ml
76.7
121.8
1.68
15
54
(3000012) Reticulocyte production index
18
52
3.49
5.46
1.4
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
176
2.25
5.22
1.3
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
145
2.38
5.17
2.3
2.8
nmol/l
0.9
0.9
0.02
27
103
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
272
2075
1.38
5.17
3.1
3.0
e6/l
0.7
0.9
1.15
176
1181
(3037467) Urinalysis macro (dipstick) panel - Urine
897
8045
1.28
5.14
4.3
3.9
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
23
4.81
5.01
1.2
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
33
3.96
4.71
5.0
5.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
28
115
2.46
4.64
7.1
8.6
%
11.5
11.5
0.01
28
115
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
43
3.51
4.62
1.3
1.4
%
57.5
92.6
—
10
23
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
13
34
3.85
4.54
1.4
1.1
%
83.4
91.5
—
5
13
(3000330) Specific gravity of Urine by Test strip
76
455
1.71
4.53
2.9
3.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
383
3130
1.30
4.51
3.2
2.9
umol/l
2810.9
4926.8
0.70
354
2782
(3021960) Folate [Moles/volume] in Serum or Plasma
301
2382
1.33
4.47
1.5
1.5
nmol/l
20.4
20.2
0.08
269
2051
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
66
382
1.76
4.43
2.3
2.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
151
1074
1.45
4.27
4.4
2.9
g/l
10.0
10.3
0.42
146
994
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
31
139
2.26
4.26
1.9
3.5
%
14.5
10.2
1.06
24
91
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
47
248
1.92
4.24
1.4
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
101
664
1.56
4.17
3.7
3.5
pmol/l
4.5
4.7
0.74
89
597
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
13
6.96
4.16
1.7
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
60
346
1.76
4.10
5.4
3.4
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
7
7
10.04
4.01
2.4
3.6
mmol/l
4.1
4.3
—
7
7
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
155
1122
1.42
4.00
3.3
3.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
114
779
1.50
3.96
2.0
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
70
2.74
3.92
1.3
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
8
8.78
3.77
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
67
409
1.67
3.76
1.9
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
41
216
1.92
3.75
2.7
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
66
402
1.67
3.74
1.4
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
987
9137
1.22
3.52
3.1
3.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
331
2734
1.27
3.50
2.9
2.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
64
395
1.65
3.47
2.0
1.5
u/ml
271.1
234.3
0.43
48
215
(3035880) pH of Pleural fluid
15
52
2.90
3.47
1.3
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
18
5.02
3.37
1.1
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
10
7.02
3.36
2.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
68
430
1.61
3.36
1.6
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
50
293
1.73
3.29
1.9
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
247
1983
1.29
3.27
3.2
3.2
e6/l
1.9
1.6
0.18
151
1096
(3011412) CD3 cells [#/volume] in Blood
33
170
1.96
3.25
2.2
3.4
e9/l
0.8
1.4
4.26
24
104
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
72
2.52
3.21
1.3
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
124
899
1.41
3.21
3.3
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
46
266
1.75
3.18
5.1
4.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
229
1.81
3.18
1.2
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
44
252
1.77
3.15
4.5
5.0
kpa
8.6
8.8
0.43
44
247
(3012501) Base excess in Blood by calculation
44
252
1.77
3.15
4.5
5.0
mmol/l
1.8
2.5
1.17
33
161
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
79
2.42
3.14
1.4
1.9
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
44
253
1.76
3.11
4.5
5.0
kpa
5.0
5.0
0.19
44
248
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
28
139
2.03
3.06
1.3
1.5
pmol/l
396.1
304.9
0.31
22
115
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
32
167
1.94
3.06
1.4
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
74
2.45
3.05
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
18
75
2.42
2.97
1.1
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
57
2.65
2.97
1.5
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
27
135
2.02
2.91
2.3
3.7
e9/l
0.2
0.2
0.38
21
112
(3003181) Sodium [Moles/volume] in Urine
36
199
1.83
2.91
1.2
1.5
mmol/l
79.9
69.3
0.51
29
168
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
89
2.26
2.87
1.5
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
334
2827
1.23
2.81
4.8
4.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
91
641
1.45
2.79
1.8
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
173
1.87
2.78
2.8
2.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
27
138
1.97
2.76
2.3
3.6
e6/l
287.6
632.2
3.75
21
112
(3020630) Protein [Mass/volume] in Serum or Plasma
118
873
1.38
2.75
2.4
3.0
g/l
63.0
66.6
4.59
112
808
(3029937) Albumin [Presence] in Urine by Test strip
356
3043
1.22
2.72
4.0
3.5
estimate
0.0
0.0
0.32
114
1043
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
114
840
1.39
2.72
4.5
4.2
mmol/l
1.2
1.2
0.00
104
736
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
153
1.91
2.71
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
54
2.61
2.70
1.6
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
105
2.11
2.69
1.3
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
105
2.11
2.69
1.3
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
105
2.11
2.69
1.3
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
317
2681
1.23
2.68
3.8
3.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
92
2.19
2.67
2.1
3.9
e6/l
300.7
313.4
0.07
14
59
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
32
3.14
2.65
2.6
2.3
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
5
7
7.16
2.55
1.6
1.6
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
6
11
5.47
2.54
1.5
2.1
umol/l
30.3
28.6
—
6
11
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
63
2.39
2.46
1.3
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
63
2.39
2.46
1.3
1.8
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
12
45
2.68
2.45
1.8
2.9
umol/l
26.7
35.7
—
7
33
(3033882) Carnitine [Moles/volume] in Serum or Plasma
6
12
5.01
2.40
1.5
1.8
umol/l
37.8
35.9
—
6
12
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
22
3.65
2.36
1.3
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
275
1.62
2.36
2.5
2.3
g/l
130.2
133.4
0.36
32
203
(4094501)
49
324
1.53
2.10
1.1
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
53
358
1.50
2.07
1.4
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
58
0.00
2.04
0.0
3.3
—
47.2
—
0
58
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
73
527
1.40
2.03
2.0
2.2
—
—
—
0
0
(3000492) Spirometry study
162
1314
1.26
2.02
1.5
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
476
4279
1.16
2.00
1.9
1.9
pmol/l
95.4
95.7
0.06
278
2344
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
119
1.86
1.97
3.6
2.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
141
1.79
1.97
1.6
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
19
99
1.93
1.90
1.6
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
410
3656
1.17
1.90
3.4
3.4
mmol/l
2.3
2.4
0.92
364
3257
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
45
300
1.52
1.89
1.4
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
209
1758
1.22
1.88
1.6
1.7
nmol/l
1293.3
1170.9
1.19
164
1352
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
291
0.51
1.87
1.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
115
904
1.29
1.85
4.7
4.7
%
0.0
0.5
0.66
33
237
(3035285) Chloride [Moles/volume] in Venous blood
22
122
1.81
1.84
3.6
2.6
mmol/l
105.8
105.4
0.24
22
122
(3041354) Potassium [Moles/volume] in Venous blood
22
122
1.81
1.84
3.6
2.6
mmol/l
3.9
4.1
0.99
22
122
(3014765) Yersinia sp identified in Stool by Organism specific culture
52
360
1.46
1.83
1.4
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
12
53
2.27
1.81
2.5
2.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
165
0.42
1.79
1.1
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
120
955
1.28
1.77
4.6
4.6
%
0.2
0.1
0.24
38
282
(3024891) Influenza virus A+B Ag [Presence] in Specimen
58
413
1.42
1.77
1.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
618
5703
1.14
1.75
3.7
3.2
estimate
0.0
0.0
0.00
123
1054
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
25
147
1.71
1.74
1.9
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
12
54
2.23
1.74
1.8
2.7
u/l
218.8
197.1
0.62
12
54
(3021601) Nitrite [Presence] in Urine by Test strip
618
5708
1.14
1.72
4.9
4.5
estimate
0.0
0.0
0.50
127
1094
(42529406) Shigella sp [Presence] in Stool by Culture
52
365
1.44
1.72
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
65
476
1.38
1.70
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
201
1702
1.21
1.70
1.7
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
125
1006
1.26
1.69
4.6
4.6
%
0.8
0.8
0.01
39
308
(3021901) Oxygen saturation in Capillary blood
35
227
1.55
1.68
5.6
3.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
31
2.59
1.66
1.3
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
31
2.59
1.66
1.3
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
20
112
1.80
1.65
1.2
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
29
181
1.61
1.64
1.9
2.1
mmol/l
1.6
1.6
0.19
29
174
(4034850)
51
361
1.43
1.63
13.4
8.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
32
2.51
1.59
1.1
2.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
167
1.63
1.59
1.6
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
114
916
1.26
1.58
4.4
4.4
%
0.8
0.5
0.78
30
223
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
157
0.44
1.55
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
909
8644
1.13
1.52
3.7
3.4
u/l
49.2
50.9
0.32
859
8195
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
93
1.84
1.51
2.6
2.9
%
31.7
40.5
—
9
26
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
218
0.50
1.51
1.2
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
212
1827
1.19
1.50
2.0
3.1
mmol/l
2.4
2.4
0.73
177
1605
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
268
0.56
1.48
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
268
0.56
1.48
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
267
0.56
1.47
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
267
0.56
1.47
1.2
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
479
4394
1.13
1.44
3.8
3.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
214
0.51
1.44
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
424
0.65
1.43
1.2
1.3
miu/ml
90.1
225.5
—
10
194
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
12
59
2.04
1.43
1.4
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
39
2.32
1.43
1.6
2.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
213
0.51
1.42
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
43
304
1.43
1.41
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
40
2.26
1.40
1.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
14
74
1.90
1.39
1.2
1.2
ratio
1.1
1.1
—
5
27
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
67
1.95
1.38
1.0
1.2
iu/ml
175.3
237.6
0.48
13
67
(3007566) Smooth muscle Ab [Titer] in Serum
51
374
1.38
1.37
1.4
1.3
titre
75.0
85.3
—
6
36
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
23
2.61
1.37
1.3
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
23
2.61
1.37
1.7
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
618
5772
1.12
1.36
3.8
3.3
estimate
0.0
0.0
0.50
125
1027
(3011288) Drugs identified in Urine by Screen method
37
524
0.70
1.36
2.5
3.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
12
61
1.97
1.33
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
24
2.51
1.30
1.3
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
69
1.89
1.28
1.1
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
61
466
1.32
1.28
2.2
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
82
653
1.27
1.27
3.9
2.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
25
2.41
1.24
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
83
664
1.26
1.24
1.3
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
36
2.23
1.24
1.3
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
12
63
1.91
1.23
4.0
7.3
g/mol
195.0
78.0
0.30
12
55
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
142
0.49
1.21
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
23
148
1.56
1.20
2.3
3.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
117
978
1.21
1.18
3.2
3.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
26
2.31
1.18
1.5
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
235
2086
1.15
1.17
1.6
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
60
766
0.77
1.15
2.0
2.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
15
87
1.73
1.15
2.3
2.9
umol/l
1.8
1.8
0.02
15
82
(3035320) C reactive protein [Mass/volume] in Body fluid
16
95
1.69
1.14
5.1
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
200
1.46
1.12
1.3
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
151
1.53
1.12
2.4
3.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
73
1.79
1.11
1.8
2.6
u/field
0.2
1.7
—
5
40
(3029634) Reagin Ab [Titer] in Serum by VDRL
32
226
1.42
1.10
2.2
2.4
—
4.0
—
0
5
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
31
2.26
1.10
1.3
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
162
0.55
1.08
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
62
780
0.79
1.08
1.9
2.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
52
1.93
1.06
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
32
228
1.41
1.06
3.2
4.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
33
2.13
1.05
1.1
3.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
17
265
0.64
1.05
1.5
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
38
509
0.74
1.05
1.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
62
775
0.79
1.03
1.9
2.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
75
1.74
1.03
2.8
3.0
u/ml
1362.2
1121.7
0.12
13
75
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
196
1.44
1.02
1.2
1.1
—
—
—
0
0
(4306422)
27
188
1.44
1.01
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
106
0.47
1.01
1.0
1.0
—
—
—
0
0
(4010399)
99
830
1.21
1.00
1.6
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
109
0.46
1.00
1.0
1.1
mg/l
314.0
274.4
—
5
96
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
25
356
0.70
1.00
1.4
2.1
mg/l
423.7
500.7
1.17
25
337
(3028300) Cannabinoids [Presence] in Urine
63
783
0.80
1.00
2.2
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
248
1.38
1.00
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
35
2.00
1.00
1.4
2.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
49
1.84
0.98
5.3
8.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
39
513
0.75
0.97
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
173
1953
0.87
0.96
2.0
1.9
%
1.6
1.5
0.36
155
1750
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
438
4085
1.10
0.95
4.2
3.8
%
23.7
21.4
1.73
207
1779
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
55
435
1.27
0.95
1.5
2.5
u/l
8250.5
3918.6
0.27
15
159
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
351
3238
1.11
0.95
1.7
1.7
mmol/l
1.4
1.4
0.13
302
2762
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
373
1.30
0.95
1.6
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
51
1.77
0.94
2.3
2.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
133
1.51
0.94
1.7
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
442
4719
0.91
0.92
2.6
2.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
53
421
1.27
0.90
1.2
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
245
1.35
0.89
3.2
2.8
%
16.9
16.9
0.02
17
135
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
230
0.65
0.89
1.0
1.1
u/ml
1.6
3.9
—
7
104
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
77
922
0.83
0.88
1.5
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
42
1.91
0.88
4.6
3.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
48
378
1.28
0.87
1.3
1.3
—
1688.0
—
0
5
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
80
1.63
0.84
2.4
2.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
80
1.63
0.84
2.4
2.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
44
345
1.28
0.83
1.4
1.5
ug/g
269.1
292.2
0.25
23
206
(21494755) Public health laboratory ask at order entry panel
131
1491
0.87
0.83
1.4
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
114
0.52
0.83
1.5
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
36
276
1.31
0.81
1.9
1.7
e6/l
14904.4
15718.4
0.05
25
205
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
190
1.37
0.79
7.7
4.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
33
1.82
0.79
1.2
2.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
48
1.67
0.78
1.6
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
616
0.81
0.78
2.1
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
210
0.66
0.77
1.5
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
252
1.32
0.77
3.1
3.9
%
55.9
55.2
0.12
33
252
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
302
2798
1.10
0.76
1.9
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
56
459
1.23
0.75
1.9
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
116
1319
0.87
0.74
1.6
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
128
1130
1.14
0.74
2.3
2.7
u/l
31.1
82.0
0.67
108
993
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
24
2.09
0.74
1.6
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
245
1.31
0.74
2.6
3.5
e9/l
3.6
4.0
0.40
32
245
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
56
1.61
0.72
1.1
1.3
—
67.8
—
0
9
(3028707) Methadone [Presence] in Urine by Screen method
28
366
0.76
0.71
2.9
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
120
1356
0.88
0.71
1.8
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
61
727
0.83
0.70
1.9
2.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
286
0.73
0.70
2.3
2.5
ug/min
90.0
100.4
0.06
16
165
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
37
292
1.27
0.70
1.9
2.5
g/l
0.0
0.0
0.50
31
277
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
58
1.55
0.69
1.1
1.1
%
94.8
86.0
—
9
58
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
58
1.55
0.69
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
31
239
1.30
0.69
1.0
1.1
—
—
—
0
0
(4027681)
5
91
0.55
0.67
1.4
1.2
—
—
—
0
0
(4015189)
5
28
1.79
0.66
1.6
2.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
431
1.21
0.65
1.7
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
183
1669
1.11
0.65
1.4
1.3
titre
515.0
498.5
0.04
40
322
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
360
0.77
0.65
1.0
1.2
u/ml
2.4
7.7
2.81
15
233
(3026389) Candida sp identified in Specimen by Organism specific culture
17
120
1.42
0.64
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
34
269
1.27
0.64
1.3
2.5
g/l
0.0
0.0
0.00
28
254
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
37
296
1.26
0.64
1.7
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
13
87
1.50
0.63
1.7
2.0
mg/l
3.2
3.4
0.18
13
82
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
71
1.55
0.62
2.7
3.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
49
1.64
0.62
1.8
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
147
1.37
0.61
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
184
1686
1.10
0.60
1.5
1.5
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
21
0.00
0.60
0.0
1.6
—
9.0
—
0
7
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
36
1.67
0.56
3.3
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
36
1.67
0.56
3.3
3.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
98
1.43
0.56
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
98
1.43
0.56
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
98
1.43
0.56
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
318
2996
1.08
0.56
2.9
2.8
ug/l
0.7
0.7
0.06
191
1835
(3050129) First trimester maternal screen panel - Serum or Plasma
26
330
0.78
0.56
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
172
0.70
0.56
1.4
3.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
37
303
1.23
0.54
1.1
1.2
u/ml
2.1
9.5
—
5
40
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
33
267
1.24
0.54
1.3
2.5
g/l
0.0
0.0
0.00
28
253
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
147
0.68
0.53
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
74
1.49
0.53
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
108
1.39
0.53
1.7
2.4
mg/l
19.9
18.4
—
8
34
(46235355) HIV 1 and 2 tests - Meaningful Use set
279
2623
1.08
0.53
2.0
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
249
0.76
0.53
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
166
1802
0.91
0.52
1.2
1.2
u/ml
5.8
10.4
0.52
63
712
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
97
0.62
0.52
1.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
28
347
0.80
0.51
1.0
1.2
u/ml
1.2
1.2
0.02
15
209
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
347
0.80
0.51
1.0
1.1
u/ml
7.2
3.8
—
5
97
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
314
0.79
0.51
1.6
2.3
e6/l
3.8
39.8
1.13
19
237
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
25
314
0.79
0.51
1.6
2.3
e6/l
289.0
866.1
0.67
19
247
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
101
1.39
0.49
1.4
1.4
u/ml
5.1
0.3
—
9
45
(3016650) Hepatitis A virus Ab [Presence] in Serum
30
244
1.23
0.48
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
46
1.52
0.48
1.1
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
46
1.52
0.48
2.7
5.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
46
1.52
0.48
1.4
2.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
93
1.40
0.48
1.3
1.5
g/l
1.0
1.0
0.18
13
93
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
299
1.21
0.48
1.5
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
102
1.38
0.47
1.1
1.1
—
—
—
0
0
(4035726)
104
940
1.11
0.47
1.9
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
209
1.25
0.46
1.9
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
39
328
1.19
0.46
1.7
2.6
g/l
0.3
1.1
2.31
31
300
(3019832) Treponema pallidum Ab [Presence] in Serum
117
1282
0.91
0.46
1.9
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
94
1.39
0.46
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
18
138
1.31
0.45
1.1
1.3
nmol/l
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
121
0.66
0.45
10.5
14.3
nmol/l
891.4
807.0
—
8
115
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
51
1.37
0.44
1.6
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
121
1108
1.10
0.44
1.5
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
57
1.41
0.42
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
57
1.41
0.42
1.3
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
20
158
1.27
0.42
1.1
1.3
nmol/l
0.5
0.6
0.65
20
151
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
21
167
1.26
0.42
1.3
1.4
pmol/l
61.2
136.5
0.62
21
162
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
229
2160
1.07
0.41
1.5
1.7
pmol/l
104762339.3
40869987.3
0.38
189
1840
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
26
213
1.22
0.41
2.3
3.9
u/ml
869.9
259.4
0.33
26
200
(3004716) Salmonella sp identified in Stool by Organism specific culture
76
682
1.12
0.40
1.5
1.3
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
5.4
—
3.8
—
0
17
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
17
0.00
0.40
0.0
10.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
60
1.34
0.40
1.1
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
131
1211
1.09
0.40
2.6
2.4
nmol/l
360.5
361.1
0.01
119
1134
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
137
0.73
0.39
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
48
547
0.87
0.38
1.5
1.8
mg/l
2.6
3.6
0.85
33
389
(40768441) Liver Pathology biopsy report
13
98
1.33
0.37
1.4
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
113
0.71
0.37
3.4
4.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
140
1502
0.93
0.37
2.1
2.3
nmol/l
13.0
13.5
0.31
125
1342
(3037556) Urate [Mass/volume] in Serum or Plasma
5
37
1.35
0.37
1.2
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.6
2.4
umol/l
27.2
16.1
—
5
37
(3003740) Influenza virus B Ag [Presence] in Specimen
34
290
1.18
0.37
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
180
1912
0.93
0.37
1.2
1.3
iu/ml
40.4
31.1
0.35
45
564
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
300
1.17
0.36
1.9
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
41
470
0.87
0.36
1.8
1.9
pmol/l
209.2
218.1
0.22
41
445
(3002523) Influenza virus A Ag [Presence] in Specimen
34
291
1.17
0.36
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
76
0.66
0.35
1.4
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
80
0.62
0.35
1.8
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
329
3158
1.05
0.35
3.2
3.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
50
564
0.88
0.35
2.0
1.8
u/l
8.3
6.7
0.43
44
431
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
135
1.26
0.35
1.1
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.7
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
156
0.77
0.34
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
526
5110
1.04
0.34
4.2
4.3
ug/l
2.0
2.3
0.68
468
4636
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
82
1.34
0.34
1.2
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
91
1.32
0.33
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
30
256
1.18
0.33
1.3
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
296
0.84
0.33
1.6
2.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
88
0.68
0.33
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
89
0.67
0.33
1.0
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
47
1.28
0.32
1.2
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
92
1.31
0.32
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
48
538
0.89
0.31
2.0
2.1
u/l
34.2
40.2
1.21
40
484
(3022145) Colonoscopy Study observation
124
1325
0.93
0.31
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
20
165
1.21
0.31
1.3
1.6
nmol/l
0.3
0.3
0.02
14
130
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
1.1
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
1.1
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
202
1.19
0.31
1.2
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
27
230
1.18
0.31
4.4
3.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
19
156
1.22
0.31
1.1
1.3
nmol/l
—
0.4
—
0
10
(3049717) Cytology report of Urine Cyto stain
48
428
1.13
0.31
2.1
2.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
353
1.14
0.30
2.0
2.3
g/l
3.3
3.1
0.69
30
284
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.6
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.6
2.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
55
1.27
0.30
2.6
2.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.6
2.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.6
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
102
1.28
0.30
2.2
2.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
102
1.28
0.30
2.1
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
20
166
1.21
0.30
1.6
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
60
544
1.11
0.29
1.6
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
49
439
1.12
0.29
1.2
1.2
u/ml
0.3
1.0
—
8
33
(40768443) Skin Pathology biopsy report
52
468
1.12
0.29
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
125
1330
0.93
0.29
4.1
4.2
%
31.7
31.0
0.27
93
935
(40768800) Prostate Pathology biopsy report
25
291
0.86
0.28
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
46
412
1.12
0.28
3.0
3.7
u/ml
86.3
3501.4
0.77
38
346
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
151
0.79
0.28
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
248
0.84
0.28
1.0
1.1
u/ml
2.2
6.4
—
6
114
(3024263) Appearance of Synovial fluid
8
62
1.29
0.28
2.3
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
62
1.29
0.28
1.3
2.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
34
299
1.14
0.27
1.3
2.4
g/l
37.7
38.2
0.14
28
265
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
66
1.21
0.26
1.3
3.1
ug/l
20.7
141.4
—
8
59
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
86
1.28
0.26
2.1
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
72
0.69
0.26
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
149
0.80
0.25
1.5
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
132
1.21
0.25
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
138
0.80
0.25
2.2
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
235
1.15
0.25
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
235
1.15
0.25
1.6
1.7
g/l
0.9
0.9
0.02
18
183
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
311
1.13
0.25
3.8
3.5
mg/l
33.8
34.8
0.04
26
248
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
311
1.13
0.25
3.8
3.5
mg/l
31.4
73.2
1.29
25
246
(3038177) Helicobacter pylori Ab [Presence] in Serum
23
198
1.16
0.24
1.1
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
76
1.19
0.24
2.3
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
63
683
0.92
0.24
2.6
2.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
48
436
1.10
0.24
1.7
1.6
iu/ml
13.8
0.1
—
9
82
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
302
3118
0.96
0.24
1.3
1.4
u/ml
2.8
1.8
0.39
81
797
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
38
1.32
0.23
3.0
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
36
400
0.90
0.22
1.4
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
40
1.25
0.22
1.6
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
276
1.13
0.22
2.4
1.8
iu/l
2.4
5.5
3.13
14
94
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
27
238
1.14
0.22
1.1
1.2
u/ml
23.4
30.4
—
5
23
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
20
172
1.16
0.22
1.3
1.3
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
38.4
—
0
10
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
182
1.16
0.21
2.0
1.8
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.3
—
0
6
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
126
1.19
0.21
1.1
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
43
1.16
0.21
1.0
1.3
ug/l
14.3
8.8
—
5
43
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(44813793)
9
113
0.80
0.20
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
165
0.85
0.19
2.1
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
112
1176
0.95
0.19
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
57
611
0.93
0.18
1.6
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
17
147
1.16
0.18
1.2
1.1
%
78.7
97.4
1.47
17
139
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
85
805
1.06
0.18
1.2
1.3
au/ml
20.3
58.5
—
5
33
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
233
1.12
0.17
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
84
796
1.06
0.17
1.2
1.2
iu/ml
95.8
154.2
1.07
32
287
(3004451) EKG impression Narrative
7
63
1.11
0.17
1.3
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
66
0.76
0.17
1.0
1.6
ug/l
4.4
6.5
—
5
56
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
148
1.15
0.17
1.1
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
246
0.89
0.16
1.1
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
379
1.08
0.16
2.0
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
379
1.08
0.16
2.0
2.3
g/l
6.9
7.2
0.54
30
293
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
379
1.08
0.16
2.0
2.3
g/l
3.6
3.9
0.76
29
278
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
350
1.09
0.16
2.1
2.3
g/l
9.9
10.5
0.40
31
307
(3036071) Salmonella sp Ab [Titer] in Serum
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
(4024509)
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
70
739
0.94
0.15
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
507
1.07
0.15
3.2
5.0
g/l
0.3
0.3
0.31
33
281
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
255
0.90
0.15
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
80
762
1.05
0.14
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
80
839
0.95
0.14
2.6
3.1
e9/l
3.9
4.1
0.43
67
690
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
87
0.80
0.14
1.4
1.6
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
131
1.15
0.14
1.1
1.3
u/ml
0.9
2.2
—
7
74
(3012516) Albumin [Mass/volume] in Urine
332
3255
1.03
0.14
3.3
3.4
mg/l
350.2
234.6
0.22
222
2205
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
431
1.07
0.14
1.1
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
189
1.11
0.13
1.9
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
218
1.10
0.13
1.3
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
100
0.80
0.13
1.8
1.2
mmol/l
2.7
2.0
—
8
93
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
149
0.87
0.13
1.5
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
166
1612
1.03
0.13
1.9
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
148
0.88
0.12
1.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
63
600
1.05
0.12
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
36
385
0.93
0.12
1.1
1.2
u/ml
0.6
2.3
1.88
19
213
(3007164) IgA [Mass/volume] in Serum or Plasma
293
2878
1.02
0.11
1.7
1.6
g/l
2.2
2.3
0.54
200
1722
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
147
0.88
0.11
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
240
0.92
0.11
1.5
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
86
1.16
0.11
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
146
0.89
0.10
1.5
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
97
1001
0.97
0.10
3.4
4.4
ug/l
3.1
21.9
1.56
79
824
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
180
1762
1.02
0.09
2.0
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
114
0.88
0.09
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
145
0.90
0.09
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
145
0.90
0.09
1.2
1.2
—
—
—
0
0
(4062490)
16
145
1.10
0.09
1.4
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
116
1.12
0.09
1.1
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
20
184
1.09
0.09
1.7
2.2
—
1508.6
—
0
7
(1617658) Protocol used for examination of sentinel lymph nodes
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
226
0.93
0.08
1.0
1.1
u/ml
14.3
6.9
—
7
105
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
146
1.10
0.08
1.4
1.3
g/l
1.7
2.7
2.22
11
103
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
146
1.10
0.08
1.4
1.3
g/l
0.3
0.4
0.56
11
101
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
146
1.10
0.08
1.4
1.3
g/l
7.4
6.6
0.20
11
103
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
63
0.79
0.08
7.0
7.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
64
0.78
0.08
2.0
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
64
0.78
0.08
2.0
3.0
ml
1790.8
2058.4
—
5
58
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
346
3421
1.01
0.07
3.6
4.2
mg/mmol
7.1
9.5
0.74
231
2288
(3023323) Follitropin [Units/volume] in Serum or Plasma
54
520
1.04
0.07
1.8
1.7
iu/l
28.3
18.9
1.15
46
405
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
89
1.12
0.07
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
89
1.12
0.07
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
67
689
0.97
0.06
2.5
2.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
90
880
1.02
0.06
2.2
2.3
au/ml
17.9
20.6
—
6
51
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
141
0.92
0.05
2.1
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
156
1539
1.02
0.05
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
209
0.96
0.03
2.0
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
229
0.96
0.03
1.3
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
168
1694
0.99
0.02
2.4
3.0
ug/g
117.0
134.6
0.29
132
1398
(3009508) Creatinine [Moles/volume] in Urine
381
3827
0.99
0.02
3.2
3.6
mmol/l
7.8
8.4
1.68
331
3291
(3019225) pH of Specimen
101
1022
0.99
0.02
2.7
4.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
851
0.99
0.02
2.5
2.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
198
0.96
0.02
1.7
1.7
—
—
—
0
0
(4198724)
12
113
1.06
0.02
1.3
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
257
2582
0.99
0.01
4.2
3.3
kg/l
1.0
1.0
0.97
45
359
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
123
1220
1.01
0.01
1.5
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
163
1.04
0.01
2.9
4.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
10
94
1.06
0.01
1.2
1.1
—
79.0
—
0
6
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
16
166
0.96
0.00
1.3
1.4
pmol/l
102.6
65.4
—
7
51
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
244
1.02
0.00
3.4
3.6
mg/l
13.8
27.8
4.30
19
150
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
96
1.04
0.00
1.1
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
206
1.02
0.00
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
118
1.02
0.00
2.5
2.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
99
1.01
0.00
2.2
2.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
12
119
1.01
0.00
1.0
1.1
—
7.6
—
0
27
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
472
4722
1.00
0.00
2.6
2.4
nmol/l
77.2
73.5
1.88
434
4313
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
127
1.02
0.00
1.1
1.3
nmol/l
1.7
1.4
0.42
13
110
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
23
235
0.98
0.00
5.0
3.6
nmol/l
21.8
22.4
0.08
23
227
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
6
62
0.97
0.00
2.5
2.1
nmol/l
0.0
0.1
—
6
43
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044336) Cobalt [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
14.2
—
0
6
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
6.6
—
0
9
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
180
1.00
0.00
1.5
1.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
56
0.89
0.00
1.0
1.7
—
11.6
—
0
5
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
14.8
—
0
9
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
223.6
—
0
8
(4281824)
6
69
0.87
0.00
1.2
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
69
0.87
0.00
1.3
1.7
—
909464.3
—
0
7
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
515.8
—
0
5
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
72
0.97
0.00
5.6
2.7
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
9
89
1.01
0.00
5.1
4.3
ug/l
3.3
1.6
—
9
83
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.9
—
1.8
—
0
7
(3014271) Vancomycin [Susceptibility]
5
49
1.02
0.00
2.4
2.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
96
0.94
0.00
2.2
1.8
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
199.7
—
0
8
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
0.4
—
0
5
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
9
0.00
0.00
0.0
2.9
—
0.4
—
0
9
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
616.2
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
72
0.97
0.00
11.1
5.4
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
65
0.92
0.00
1.0
1.4
u/l
176.5
436.1
—
6
58
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
5.0
—
420.4
—
0
9
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_AORTIC_MITRAL_VALVES – Congenital malformations of aortic and mitral valves
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).